Involvement of androgen receptor in nitric oxide production induced by icariin in human umbilical vein endothelial cells

FEBS Letters

Volumn 584, Issue 11, 2010, Pages 2440-2444

  Koizumi, Hideki ^a   Yu, Jing ^a   Hashimoto, Ryo ^a   Ouchi, Yasuyoshi ^a   Okabe, Tetsuro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Androgen receptor; Endothelial cells; Endothelial nitric oxide synthase; Icariin; Nitric oxide

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANDROGEN RECEPTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ICARIIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; NILUTAMIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SERINE; SMALL INTERFERING RNA; THREONINE; TYROSINE; WORTMANNIN;

ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME RELEASE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; UMBILICAL VEIN;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; ENDOTHELIAL CELLS; ENDOTHELIUM; FLAVONOIDS; HUMANS; IMIDAZOLIDINES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, ANDROGEN; UMBILICAL VEINS;

EID: 77952954315     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.04.049     Document Type: Article

References (19)

1. Ye L.C., Chen J.M. Advances in study on pharmacological effects of Epimedium. Chin. J. Chin. Mater. Med. 2001, 26:293-295.
2. Guo B.L., Xiao P.G. Comment on main species of herba epimedii. Chin. J. Chin. Mater. Med. 2003, 28:303-307.
3. Pietta P.G., Mauri P.L., Manera E., Ceva P.L., Rava A. An improved HPLC determination of flavonoids in medical plant extracts. Chromatographia 1989, 27:509-512.
4. Xu H.B., Huang Z.Q. Vasorelaxant effects of icariin on isolated canine coronary artery. J. Cardiovasc. Pharmacol. 2007, 49:207-213.
5. Yu S., Chen K., Li S., Zhang K. In vitro and vivo studies of the effects of a Chinese herb medicine on osteoclastic bone resorption. Chin. J. Dent. Res. 1999, 2:7-11.
6. Xiao P.G., Xing S.T., Wang L.W. Immunological aspects of Chinese medicine plants as antiageing drugs. Journal of Ethnopharmacology 1993, 38:167-175.
7. Ning H., Xin Z.C., Lin G., Banie L., Lue T.F., Lin C.S. Effects of icariin on phosphodiesterase-5 activity in vitro and cyclic guanosine monophosphate level in cavernous smooth muscle cells. Urology 2006, 68:1350-1354.
8. Dell'Agli M., Galli G.V., Dal Cero E., Belluti F., Matera R., Zironi E., Pagliuca G., Bosisio E. Potent inhibition of human phosphodiesterase-5 by icariin derivatives. J. Nat. Prod. 2008, 71:1513-1517.
9. Xu H.B., Huang Z.Q. Icariin enhances endothelial nitric-oxide synthase expression on human endothelial cells in vitro. Vascul. Pharmacol. 2007, 47:18-24.
10. Zhang Z.B., Yang Q.T. The testosterone mimetic properties of icariin. Asian J. Androl. 2006, 8:601-605.
11. Chung B.H., Kim J.D., Kim C.K., Kim J.H., Won M.H., Lee H.S., Dong M.S., Ha K.S., Kwon Y.G., Kim Y.M. Icariin stimulates angiogenesis by activating the MEK/ERK and PI3K/Akt/eNOS-dependent signal pathways in human endothelial cells. Biochem. Biophys. Res. Commun. 2008, 376:404-408.
12. Herman A.G., Moncada S. Therapeutic potential of nitric oxide donors in the prevention and treatment of atherosclerosis. Eur. Heart J. 2005, 26:1945-1955.
13. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schütz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., Evans R.M. The nuclear receptor superfamily: the second decade. Cell 1995, 83:835-839.
14. Yu J., Eto M., Akishita M., Kaneko A., Ouchi Y., Okabe T. Signaling pathway of nitric oxide production induced by ginsenoside Rb1 in human aortic endothelial cells: a possible involvement of androgen receptor. Biochem. Biophys. Res. Commun. 2007, 353:764-769.
15. Gonzalez E., Nagiel A., Lin A.J., Golan D.E., Michel T. Small interfering RNA-mediated down-regulation of caveolin-1 differentially modulates signaling pathways in endothelial cells. J. Biol. Chem. 2004, 279:40659-40669.
16. Nakatsubo N., Kojima H., Sakurai K., Kikuchi K., Nagoshi H., Hirata Y., Akaike T., Maeda H., Urano Y., Higuchi T., Nagano T. Improved nitric oxide detection using 2,3-diaminonaphthalene and its application to the evaluation of novel nitric oxide synthase inhibitors. Biol. Pharm. Bull. 1998, 21:1247-1250.
17. Peng X., Haldar S., Deshpande S., Irani K., Kass D.A. Wall stiffness suppresses Akt/eNOS and cytoprotection in pulse-perfused endothelium. Hypertension 2003, 41:378-381.
18. Feliers D., Chen X., Akis N., Choudhury G.G., Madaio M., Kasinath B.S. VEGF regulation of endothelial nitric oxide synthase in glomerular endothelial cells. Kidney Int. 2005, 68:1648-1659.
19. Fleming I., Busse R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 284:R1-R12.